# Irreversible Electroporation (IRE) for the Treatment of Lower Urinary Tract Symptoms (LUTS) in Men With Benign Prostatic Hyperplasia (BPH)

> **NCT07640776** · NA · NOT_YET_RECRUITING · sponsor: **Angiodynamics, Inc.** · enrollment: 40 (estimated)

## Conditions studied

- Lower Urinary Tract Symptoms (LUTS) in Men With Benign Prostatic Hyperplasia (BPH)

## Interventions

- **DEVICE:** Irreversible Electroporation

## Key facts

- **NCT ID:** NCT07640776
- **Lead sponsor:** Angiodynamics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-09
- **Primary completion:** 2027-12
- **Final completion:** 2031-06
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2026-06-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07640776

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07640776, "Irreversible Electroporation (IRE) for the Treatment of Lower Urinary Tract Symptoms (LUTS) in Men With Benign Prostatic Hyperplasia (BPH)". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07640776. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*